Emeline Colomba Selected Research

Emeline Colomba Research Topics

Disease

13	Neoplasms (Cancer) 10/2023 - 11/2018
10	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 01/2017
9	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 11/2018
8	COVID-19 02/2024 - 12/2020
3	Breast Neoplasms (Breast Cancer) 03/2024 - 11/2018
3	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2020
2	Ovarian Epithelial Carcinoma 02/2023 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 02/2023 - 01/2019
2	Microsatellite Instability 01/2023 - 01/2022
2	Infections 01/2022 - 12/2021
1	Disease Progression 03/2024
1	Fatigue 06/2023
1	Glioblastoma (Glioblastoma Multiforme) 05/2023
1	Carcinoma (Carcinomatosis) 02/2023
1	Fallopian Tube Neoplasms 02/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Sarcopenia 10/2022
1	Turcot syndrome 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Lymphopenia (Lymphocytopenia) 12/2021
1	Communicable Diseases (Infectious Diseases) 12/2021
1	Pneumonia (Pneumonitis) 11/2021
1	Leiomyomatosis 01/2021
1	Body Weight (Weight, Body) 12/2020
1	Circulating Neoplastic Cells 11/2018

Drug/Important Bio-Agent (IBA)

6	Immune Checkpoint InhibitorsIBA 02/2023 - 01/2022
5	Androgen Receptors (Androgen Receptor)IBA 03/2024 - 01/2020
4	cabozantinibIBA 11/2023 - 01/2021
4	PlatinumIBA 02/2023 - 01/2021
3	enzalutamideIBA 11/2023 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 02/2024 - 11/2021
2	Abiraterone AcetateIBA 11/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 10/2023 - 12/2021
2	darolutamideIBA 06/2023 - 01/2020
2	lenvatinibIBA 01/2023 - 01/2022
2	pembrolizumabIBA 01/2023 - 01/2022
2	Proton Pump InhibitorsIBA 10/2022 - 01/2021
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2022 - 01/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2022 - 01/2019
2	AntibodiesIBA 01/2022 - 12/2021
2	AndrogensIBA 12/2020 - 01/2020
1	Estrogen ReceptorsIBA 03/2024
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2024
1	abemaciclibIBA 03/2024
1	Cyclin-Dependent Kinase 4IBA 03/2024
1	Cyclin DIBA 03/2024
1	Bevacizumab (Avastin)FDA Link 05/2023
1	olaparibIBA 02/2023
1	NivolumabIBA 10/2022
1	Everolimus FDA Link 01/2022
1	VaccinesIBA 01/2022
1	TinIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Granzymes (Granzyme)IBA 12/2021
1	Immunoglobulin G (IgG)IBA 12/2021
1	Viral RNAIBA 12/2021
1	LipidsIBA 11/2021
1	Amino Acids FDA Link 11/2021
1	Oxygen (Dioxygen)IBA 11/2021
1	SugarsIBA 11/2021
1	PolyaminesIBA 11/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2021
1	KetonesIBA 01/2021
1	Fumarate Hydratase (Fumarase)IBA 01/2021
1	Docetaxel (Taxotere)FDA Link 12/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2020
1	Estramustine FDA Link 12/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	Testosterone (Sustanon)FDA Link 12/2020
1	apalutamideIBA 01/2020
1	abirateroneIBA 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	rucaparibIBA 01/2019
1	Epithelial Cell Adhesion MoleculeIBA 11/2018
1	VemurafenibIBA 01/2013

Therapy/Procedure

16	Therapeutics 10/2023 - 01/2017
7	Castration 03/2024 - 11/2018
5	Drug Therapy (Chemotherapy) 01/2023 - 12/2020
1	Time-to-Treatment 05/2023
1	Nephrectomy 01/2023
1	Radiotherapy 01/2022
1	Investigational Therapies (Experimental Therapy) 12/2021
1	Critical Care (Surgical Intensive Care) 11/2021
1	Ketogenic Diet 01/2021
1	Treatment Delay 01/2021
1	Neoadjuvant Therapy 12/2020
1	Artificial Respiration (Mechanical Ventilation) 12/2020